Table 2.

Gout in dyslipidemia and non-dyslipidemia groups with subgroup analyses according to age and sex.

Characteristics	Odds Ratios for Gout
	Crude †	p-Value	Partial †,‡	p-Value	Full †,§	p-Value
Total participants (n = 83,395)
Dyslipidemia	1.59 (1.54–1.66)	<0.001 *	1.50 (1.44–1.57)	<0.001 *	1.43 (1.37–1.49)	<0.001 *
Non-dyslipidemia	1		1		1
Age < 60 years, men (n = 34,370)
Dyslipidemia	1.74 (1.64–1.85)	<0.001 *	1.62 (1.51–1.74)	<0.001 *	1.51 (1.41–1.63)	<0.001 *
Non-dyslipidemia	1		1		1
Age < 60 years, women (n = 7680)
Dyslipidemia	1.56 (1.37–1.78)	<0.001 *	1.49 (1.28–1.74)	<0.001 *	1.47 (1.26–1.71)	<0.001 *
Non-dyslipidemia	1		1		1
Age ≥ 60 years, men (n = 32,020)
Dyslipidemia	1.54 (1.46–1.64)	<0.001 *	1.49 (1.40–1.60)	<0.001 *	1.42 (1.32–1.51)	<0.001 *
Non-dyslipidemia	1		1		1
Age ≥ 60 years old, women (n = 9325)
Dyslipidemia	1.41 (1.27–1.56)	<0.001 *	1.25 (1.11–1.40)	<0.001 *	1.23 (1.09–1.39)	0.001
Non-dyslipidemia	1		1		1

Abbreviations: CCI, Charlson comorbidity index; DBP, diastolic blood pressure; SBP, systolic blood pressure. * Conditional logistic regression, Significance at p < 0.05; ^† Models were stratified by age, sex, income, and region of residence; ^‡ Partially adjusted model: Adjusted for the days of statin use, total cholesterol, SBP, DBP, and fasting blood glucose; ^§ Fully adjusted model: Adjusted for the days of statin use, total cholesterol, SBP, DBP, fasting blood glucose, obesity, smoking, alcohol consumption, and CCI scores.